Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol effects on brain in transgender women
NCT03651427Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Feb 2017
- Primary completion
- Mar 2019
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Open-label, single-arm trial of estradiol in gender dysphoria (GD), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Glutamate concentration in the left hippocampus at 90 days. Status: unknown.
02
Drugs
estradiol
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on NCT03651427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03651427.